Highland Private Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Highland Private Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,003	Closed	-$498K	–	25
2022 Q3	$498K	Sell	7,003 -188	-3%	-$13.6K	0.08%	89
2022 Q2	$553K	Buy	7,191 +451	+7%	+$34.3K	0.09%	90
2022 Q1	$492K	Sell	6,740 -179	-3%	-$12K	0.07%	97
2021 Q4	$431K	Sell	6,919 -2,069	-23%	-$121K	0.05%	105
2021 Q3	$532K	Sell	8,988 -306	-3%	-$20.2K	0.08%	90
2021 Q2	$621K	Buy	9,294 +8	+0.1%	+$522	0.09%	79
2021 Q1	$587K	Buy	9,286 +1,376	+17%	+$85.6K	0.1%	77
2020 Q4	$491K	Sell	7,910 -137	-2%	-$8.42K	0.08%	81
2020 Q3	$485K	Sell	8,047 -197	-2%	-$11.9K	0.1%	74
2020 Q2	$484K	Buy	8,244 +215	+3%	+$12.9K	0.1%	70
2020 Q1	$447K	Sell	8,029 -1,592	-17%	-$97.3K	0.12%	62
2019 Q4	$617K	Buy	9,621 +2,486	+35%	+$142K	0.15%	58
2019 Q3	$361K	Buy	+7,135	New	+$335K	0.1%	70
2019 Q2	–	Sell	-5,201	Closed	-$249K	–	129
2019 Q1	$249K	Buy	5,201 +333	+7%	+$16.6K	0.08%	91
2018 Q4	$253K	Sell	4,868 -350	-7%	-$18.8K	0.09%	81
2018 Q3	$324K	Buy	5,218 +277	+6%	+$16.4K	0.11%	79
2018 Q2	$274K	Buy	+4,941	New	+$267K	0.1%	83
2018 Q1	–	Sell	-5,462	Closed	-$335K	–	107
2017 Q4	$335K	Buy	5,462 +144	+3%	+$9.01K	0.13%	66
2017 Q3	$339K	Buy	5,318 +71	+1%	+$4.15K	0.15%	60
2017 Q2	$292K	Buy	+5,247	New	+$286K	0.14%	61
2017 Q1	–	Sell	-3,725	Closed	-$218K	–	76
2016 Q4	$218K	Buy	+3,725	New	+$204K	0.11%	70
2016 Q3	–	Sell	-3,720	Closed	-$274K	–	79
2016 Q2	$274K	Buy	3,720 +165	+5%	+$11.7K	0.15%	56
2016 Q1	$226K	Buy	+3,555	New	+$224K	0.13%	64

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Highland Private Wealth Management's BMY Position: Q4 2022 in Review

Highland Private Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 7,003 shares — an estimated $498K sold.

Highland Private Wealth Management first reported a position in BMY in Q1 2016 and held it in 23 quarters. The position peaked at $621K in Q2 2021. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Highland Private Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
Highland Private Wealth Management sold 7,003 Bristol-Myers Squibb shares in Q4 2022, an estimated $498K.
Highland Private Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 23 quarters.
Highland Private Wealth Management's Bristol-Myers Squibb position peaked at $621K in Q2 2021.
2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Highland Private Wealth Management's 13F filing for Q4 2022.